|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Mar 1, 2025
|
FY2024
12 months to Mar 2, 2024
|
FY2023
12 months to Feb 25, 2023
|
FY2022
12 months to Feb 26, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Impairment expense on goodwill and intangible assets | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Other (income) expense, net | |||||
| Earnings before income taxes | |||||
| Income tax expense | |||||
| Net earnings | |||||
| Basic earnings per share (in usd per share) | |||||
| Diluted earnings per share (in usd per share) | |||||
| Weighted average basic shares outstanding (in shares) | |||||
| Weighted average diluted shares outstanding (in shares) | |||||
Loading...
